<DOC>
	<DOCNO>NCT02793622</DOCNO>
	<brief_summary>This double-blinded randomized control phase III trial 782 HIV uninfected pregnant woman child bear . HIV uninfected woman 12-20 week gestation randomize equal proportion one two intermittent preventive treatment pregnancy ( IPTp ) treatment arm : 1 ) monthly sulfadoxine-pyrimethamine ( SP ) , 2 ) monthly dihydroartemisinin-piperaquine ( DP ) . Both intervention arm either SP DP placebo ensure adequate blinding achieve study . Follow-up pregnant woman end approximately 6 week give birth . All child bear mother enrol study follow birth reach 12 month age .</brief_summary>
	<brief_title>Prevention Malaria HIV-uninfected Pregnant Women Infants</brief_title>
	<detailed_description>Pregnant woman schedule see clinic every 4 week pregnancy 1 6 week follow delivery . In addition , pregnant woman instruct come study clinic medical care avoid use outside medication . Children schedule see clinic 1 , 4 , 6 , 8 week age every 4 week reach 52 week age . Parents/guardians instruct bring child study clinic medical care avoid use outside medication . The study clinic remain open 7 day week 8 a.m. 5 p.m. Study participant see clinic every 4 week routine visit visit home request come study clinic soon possible . Pregnant woman child receive standard care designate Uganda Ministry Health guideline . Routine antenatal care include screen treatment sexually transmitted infection , blood pressure assessment , urine dipstick proteinuria , prescription iron , folate , multivitamins mebendazole . Routine care child include immunization , vitamin A supplementation , management anemia use Integrated Management Childhood Illness ( IMCI ) guideline . During routine assessment subject ask visit outside health facility use medication outside study protocol . Standardized assessment adherence do study drug administer home insecticide treat net use . A routine history physical exam perform use standardized clinical assessment form . Blood collect finger prick thick smear ( young child , heel stick may substitute finger prick ) , capillary plasma ( routine visit phlebotomy do pregnant woman ) filter paper sample . If pregnant woman parent/guardian child report fever last 24 hour patient documented temperature &gt; 38.0ËšC tympanic , patient 's thick blood smear read immediately positive patient diagnose treated malaria . If thick blood smear negative , patient manage study physician non-malarial febrile illness . If patient afebrile report recent fever , thick blood smear obtain , except follow routine test schedule . In pregnant mother , thick blood smear do mother fever use clinical care study participant . Phlebotomy routine laboratory test ( CBC ALT ) monitor potential adverse event study medication , storage plasma immunology study perform every 8 week pregnant woman . Phlebotomy routine laboratory test ( CBC ) immunology study perform 12 , 28 , 52 week age child . For pregnant woman , study drug administer time routine visit . ECGs perform measure QTc interval pregnant woman prior 1st dose study drug 2-3 hour 3rd dose study drug 20 , 28 36 week gestation . In addition finger prick capillary plasma sample collect prior perform ECGs 3rd dose study drug 20 , 28 , 36 week gestation pregnant woman .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Pregnancy confirm positive urine pregnancy test intrauterine pregnancy ultrasound Estimated gestational age 1220 week Confirmed HIV uninfected rapid test 16 year age old Resident Busia District , Uganda Provision inform consent pregnant woman unborn child Agreement come study clinic febrile episode illness avoid medication give outside study protocol Plan deliver hospital History serious adverse event SP DP Active medical problem require inpatient evaluation time screen Intention move outside Busia District , Uganda Chronic medical condition require frequent medical attention Prior SP preventive therapy antimalarial therapy pregnancy Early active labor ( documented cervical change uterine contraction )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chemoprevention</keyword>
	<keyword>Malaria</keyword>
	<keyword>Sulfadoxine-Pyrimethamine</keyword>
	<keyword>Dihydroartemisinin-Piperaquine</keyword>
</DOC>